Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4. [PDF]
Guan H +5 more
europepmc +1 more source
Blamed but not at fault: anti-obesity medication adverse effects misidentified as perioperative complications - a comprehensive review and medicolegal warning for anesthesiologists. [PDF]
Kwak HJ, Choi JJ, Lee D, Jo YY.
europepmc +1 more source
The neurobiological regulatory mechanism of brain edema. [PDF]
Tian M +5 more
europepmc +1 more source
Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trial. [PDF]
Gao R +10 more
europepmc +1 more source
Cardiovascular Risk Reduction With Tirzepatide, a Dual GIP/GLP-1 Agonist, in Patients With Type 2 Diabetes Mellitus. [PDF]
Terui S +3 more
europepmc +1 more source
Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease. [PDF]
Heerspink HJL +7 more
europepmc +1 more source
Emerging pharmacological targets in migraine therapy: CGRP and beyond. [PDF]
Atraszkiewicz D, Dahiya D.
europepmc +1 more source
Case Report: When genetic diagnosis comes late: lessons from a DEND syndrome patient successfully transitioned to sulfonylurea. [PDF]
Abreu GM +15 more
europepmc +1 more source
ABCC9/SUR2 has a Complex Expression Pattern in Human Brain Gliovascular Unit Cells, Including Astrocytes. [PDF]
Katsumata Y +19 more
europepmc +1 more source
The beta-cell sulfonylurea receptor.
Ashcroft, S +6 more
openaire +2 more sources

